1. Guest Editor’s Note: 20th Anniversary Special Section on Medical Communications

   • Rebecca Vermeulen

   Medical Communications 01 November 2009 Pages: 635 - 636

2. Surveying Medical Information Across Europe: The Present and the Future

   • Sharon Leigbton
   • Janet E. Davies

   Medical Communications 01 November 2009 Pages: 637 - 654

3. Auditing Medical Information Services Across Western Europe: A Cost-Effective Approach

   • Charlotte Wormleighton
   • Sharon Leighton

   Medical Communications 01 November 2009 Pages: 655 - 662

4. A Practical Approach to Evidence-Based Medicine for the Medical Communications Professional

   • Patrick J. Bryant
   • Michael J. Steinberg
   • Christopher M. Marrone

   Medical Communications 01 November 2009 Pages: 663 - 672

5. The Changing Roles of Medical Communications Professionals: Evolution of the Core Curriculum

   • Alicia Alexander Codogan
   • Stacey M. Fung

   Medical Communications 01 November 2009 Pages: 673 - 684

6. Surveys of Medical Liaison Practices Across the Pharmaceutical Industry: A Review

   • J. Lynn Bass
   • Christopher M. Marrone
   • Craig Klinger

   Medical Communications 01 November 2009 Pages: 685 - 695

7. Results of a Qualitative Market Research Study Evaluating the Quality of Medical Letters

   • Radeguade Fett
   • Kai Bruns
   • Sabine Lischka-Wittmann

   Medical Communications 01 November 2009 Pages: 697 - 703

8. Historical Perspective of Technologies Used in Medical Communications, Past, Present, and Future

   • Lesley Fierro
   • Donna Savulich
   • Christina Wyble

   Medical Communications 01 November 2009 Pages: 705 - 712

9. Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process

   • Parvin Fardipour
   • Gary Littman
   • Michael Krams

   Statistics 01 November 2009 Pages: 713 - 723

10. Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies

    • Parvin Fardipour
    • Gary Littman
    • Michael Krams

    Statistics 01 November 2009 Pages: 725 - 734

11. Evaluating REMS Tools: Issues in Survey Design

    • Louis A. Morris

    Drug Safety 01 November 2009 Pages: 735 - 747

12. A Matrix to Determine Health Economic Viability Throughout Product Development: A Pharmaceutical Industry Perspective

    • Michiel Hemels
    • Michael Wolden
    • Thomas R.

    Pharmacoeconomics 01 November 2009 Pages: 749 - 756

13. The Current Situation of Oncology Drug Lag in Japan and Strategic Approaches for Pharmaceutical Companies

    • Junichi Hashimoto
    • Eiji Ueda
    • Mamoru Narukawa

    Pharmacoeconomics 01 November 2009 Pages: 757 - 765